Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centre.

scientific article published on 28 August 2015

Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centre. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/BJU.13097
P698PubMed publication ID26315395
P5875ResearchGate publication ID281484301

P50authorJeremy MillarQ43189342
Wee Loon OngQ59660959
P2093author name stringPeter Royce
Paul Manohar
P2860cites workLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesQ24597052
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapyQ33863292
Are HIV-infected men vulnerable to prostate cancer treatment disparities?Q34288005
Reduced Risk of Prostate Cancer in U.S. Men with AIDSQ34292990
Prostate carcinoma among men with human immunodeficiency virus infectionQ35829970
Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virusQ36018791
Radical prostatectomy in patients infected with human immunodeficiency virusQ36454865
Prostate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literatureQ36543212
Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment.Q37343586
Screening HIV-infected patients for non-AIDS-defining malignanciesQ37439906
A systematic review of interventions for anxiety in people with HIV.Q37903329
How does active surveillance for prostate cancer affect quality of life? A systematic reviewQ38278154
Genitourinary manifestations of the acquired immunodeficiency syndromeQ40566909
Should HIV patients be considered a high risk group for the development of prostate cancer?Q42111472
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011.Q44214046
Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional studyQ44667547
Matched cohort analysis of outcomes of definitive radiotherapy for prostate cancer in human immunodeficiency virus-positive patientsQ45361552
Preliminary results of radiation therapy for prostate cancer in human immunodeficiency virus-positive patientsQ45395865
P304page(s)5-10
P577publication date2015-08-28
P1433published inBJU InternationalQ4835773
P1476titleClinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centre
P478volume116 Suppl 3

Reverse relations

cites work (P2860)
Q38869548Clinical characteristics and outcomes of HIV-seropositive men treated with surgery for prostate cancer.
Q39903015HIV and renal cell carcinoma: Experience in an Australian statewide HIV center
Q90642710Is There an Optimal Curative Option in HIV-Positive Men with Localized Prostate Cancer? A Systematic Review
Q91429973Specific immune cell and lymphatic vessel signatures identified by image analysis in renal cancer

Search more.